KU-19-19
SK-MES-1
Jurkat T cell
Hs 571.T
Basal-like triple-negative breast cancer patient-derived xenograft; UCD52
T3M-10
SUM159
GMS-10
Endothelial cell
Hs 939.T
T29H
Mz-ChA-2
OVCAR4
COLO-680N
melanoma-KO-44
CL-34
melanoma-KO-259
Breast cancer cell line
H3122
Hs 895.T
fetal human cardiac cell line
CHLA-C275.3
SW 1271
H9 ESC line
KURAMOCHI
NCI-N87
SK-MEL-30
MOG-G-UVW
NCI-H727
A3/KAW
MG63
melanoma-KO-281
melanoma-KO-165
LN-319
SLR 24
AGS
UI226 SHH Medulloblastoma tumorspheres
NB-1
melanoma-KO-62
K-562
HBEC
melanoma-KO-75
ML-1
TE-15
melanoma-KO-97
iPSC 7095
SNU719
human mesenchymal stem cells
FOB
HK1
L-540
A549 lung adenocarcinomma cell
melanoma-KO-103
melanoma-KO-285
prostate cancer cell line PC3
GCIY
OCI-Ly1
DOHH-2
KASUMI-2
RT112/84
TALL-1
melanoma-KO-266
MDA MB-361
melanoma-KO-245
SNU-869
293T
MUTZ-5
HCC-2814
melanoma-KO-238
HCC1937
RCH-ACV
CALU6
JHH-1
HDF
NCI-H23
YCC3
melanoma-KO-69
melanoma-KO-229
Fibroblast-1
PCCB-G2
RT112
HCC1187
LOVO
DBTRG-05MG
PK-45H
melanoma-KO-139
A-204
adrenergic
NME2_EVs: mEVs and sEVs were isolated from MYC::NME2 overexpressing MDA-MB231T cells.
F7
melanoma-KO-51
R225R LMNA corrected 1 hiPSCs
NIH:OVCAR-3
melanoma-KO-195
M07e cell line
S3
melanoma-KO-39
A-704
H1975
NCI-H1734
F121-9 wt mESCs
SIG-M5
KP-N-RT-BM-1
TE-6
MCFDCIS
1-7-24
melanoma-KO-52
melanoma-KO-5
melanoma-KO-55
UACC-893
TE-4
CAMA-1
NME1-EVs: mEVs and sEVs were isolated from FLAG::NME1 overexpressing MDA-MB231T cells.
NP460
HUP-T3
TE-1
RMUG-S
NCI-H1568
JHH-5
NCI-H1395
HCT-116
melanoma-KO-171
HCC2218
SNU-1076
HL60
Calu3
melanoma-KO-50
JHOS-4
KNS-60
RC9-AB230
HEK293, HelaS3, and NIH/3T3
CC-2533
OCUG-1
HPB-ALL
melanoma-KO-20
YD-15
TM-87;TM87
CC-2554
HEC-251
melanoma-KO-224
melanoma-KO-221-233
SHSY5Y
prostate cancer cell line LNCaP
R225R LMNA corrected 2 hiPSCs
Kuramochi
SK-MEL-2
U-251 MG
MHH-ES-1
KP-1NL
NCI-H82
FL Early Gilteritinib Resistant MOLM14 cells after 48hr Gilteritinib Treatment
SNU-601
PLC/PRF/5
SZ-HU-PROB-2
H1 hESC line
differentiated microglia from induced pluripotent stem cells
TGBC18TKB
RCM-1
TIG-3 TD
KYSE-270
C13*
PTt-P7-MsNL
melanoma-KO-274
SK-LMS-1
RKN
EPLC-272H
melanoma-KO-243
LV-M100 (sublcone of MDA-MB-231)
CHLA-ONH348.4
HT-1376
Hs 675.T
melanoma-KO-74
OCI-AML2
HCC-2108
OAW42
CJM
DMS 53
BHT-101
NCI-H146
MCF7
OCI-MY7
IST-MES2
PTt-P9-MsNL
CAL-78
NCI-H508
iMA
IPS
HLF
melanoma-KO-119
C2BBe1
hNSC100
melanoma-KO-157
NCI-H2066
SNU-16
Human MB3W1 group 3 medulloblastoma cell line
SJRH30
LXF-289
LK2
CCD-18Co
KYO-1
SW403
Q1508
melanoma-KO-118
CI0000034840
melanoma-KO-106
S10
BEAS2B
melanoma-KO-30
melanoma-KO-264
P12-ICHIKAWA
253J-BV
melanoma-KO-40
INA-6
MCF10A-YAP
MCF-7 human breast adenocarcinoma cell line
SW1353
G415
Panc 02.03
OVCAR8
ACCS
BEN
melanoma-KO-248
WSU-DLCL2
hESCs-CM
PTt-P6-MsNL
BxPC-3
BFTC-905
BICR 22
NHAHTDD
HLF-a
CAL-12T
HeLa cells
GAMG
MFE-319
PrEC LH
TEN
COLO 205
SK-N-FI
MC116
K7
Ls174t
JeKo-1
H1792
JHUEM-2
MTB107-R
NCC19
GM09677
WI-38
GM12893
CHLA-ONH232.1
SMMC-7721
melanoma-KO-273
MES-SA
CC-2586
NCI-H2171
CML-T1
SNU-466
Jurkat, Clone E6-1 (ATCC TIB-152)
92.1
CC-2551
Panc.05.04
melanoma-KO-58
NCI-H2073
melanoma-KO-261
human embryonic kidney cell line HEK 293T
melanoma-KO-194
KS-1
Becker
YH-13
U2OS
G-292, clone A141B1
MKN28
JHOS-2
U266
WS1
melanoma-KO-200
melanoma-KO-255
melanoma-KO-176
melanoma-KO-167
U-178
melanoma-KO-153
MCF-7 human breast cancer cells
GM12877
MJ
WIBR3dPE hESC
Kasumi-1
NCI-H854
melanoma-KO-33
MM.1S
Granta-519
JEKO-1
UCLA4
LX2
HEK293T
JM1
MOLM-16
MIA PaCa-2
melanoma-KO-73
EOL-1
EFM-19
Akata
melanoma-KO-129
CSC6
LNZ308
Rh30
F4
HuH-6
T HESC
F3
NCI-H69
BICR 56
melanoma-KO-288
LN-215
U251
melanoma-KO-164
melanoma-KO-252
SUM149PT cells
n.a.
HCC827
PLB-985
melanoma-KO-9
NCI-H292
MGH31
PC3 tumor cell line
melanoma-KO-179
HCC1419
melanoma-KO-18
CA46
melanoma-KO-23
SKBR3
MCF7 cells
SNU-878
OVCAR3 (HTB161)
melanoma-KO-126
MGC803 cells
CC-2580
MTB15R
Sw480
H13
CAL-62
A375/211 melanoma cell line
melanoma-KO-197
Mia-Paca2
melanoma-KO-283
UWB1.289+BRCA1
UM-UC-3-pcDNA
SKNEP1
IPC-298
D341 Med
UCI ADRC76
CC-2541
AGS-EBV
melanoma-KO-105
KYSE-70
NCI-H1836
GM12885
NHEK
melanoma-KO-217
A-375
SK-CO-1
TE 159.T
CHP-212
Hs 766T
NCI-H3255
Hs 294T
melanoma-KO-206
KMM-1
NCI-H1339
A4/Fuk
PDX#3 (in house)
IMR90 cells
NHDF
melanoma-KO-131
SW1990
BOFS hiPSC cl2
COV434
EB1
NB-4
COV362
NCI-H1648
COLO 684
SW 1573
melanoma-KO-211
CHP-126
melanoma-KO-267
CADO-ES1
HCC1806RR
K562 RNASE1-mutant
MCAS
MB135 parental
Hs 936.T
HepG2 cells
melanoma-KO-6
WA01 TH #2 HESC
MGH28
OVK18
JH-EsoAd1
UM-UC-3-AR-v19
F5
A2780
melanoma-KO-24
melanoma-KO-86-116
HPAF-II
melanoma-KO-279
WM902B
MDA-MB-157
F-36P
BeWo
TUHR14TKB
PARCB
OVISE
SK-BR-3
DAOY
SKmel147
8505C
reticulocytes
SCLI
NB4
CC-2561
F11
melanoma-KO-31
melanoma-KO-49
DAN-G
hTERT ipNF95.11b C
CC-7014
NCI-H1693
melanoma-KO-185
CAL-120
Raji Burkitt's (B) lymphoma cells (CDK9as)
melanoma-KO-272
melanoma-KO-80
HH
HeLa cells from ATCC (CCL-2)
KMS-12-BM
231
melanoma-KO-249
COLO-678
IM95
melanoma-KO-48
melanoma-KO-83
CPC-N
IGR-39
LS411N
RUES2
LN-18
MDA-MB-468
CSC8
KD
COR-L105
melanoma-KO-246
HeLa cell lines
HCC4006
NAMALWA
SNU-1079
melanoma-KO-36
COV644
MOLT-16
CC-2555
SNU-626
JURKAT
PLC-8024
MKN74
melanoma-KO-143
MC3T3
HNES3
OV56
melanoma-KO-257
Set-2
Z138
IPSC-L1C1
SJ
D283 Med
Hs 888.T
NCI-H1573
H9 human neural stem cells
LNCaP tumor cell line
LNCaP/AR
23132/87
GM12891
SNU-46
melanoma-KO-140
melanoma-KO-136
ZR-75-1
HCC2157
G401
SH-4
melanoma-KO-54
MEF2C
TT2609-C02
A172
melanoma-KO-88
SF-172
SNU-1040
EKVX
UACC-62
melanoma-KO-12
melanoma-KO-26
Sk-ChA-1
KMRC-3
A549
NCI-H1694
PC-3
TE 441.T
SCLC-21H
Neuron-L1C1
IST-MES1
G510NS
OCI-C5x single-cell clonal population
SNU-899
SA
melanoma-KO-99
HNES1
IPSC-L2C2
HUES8
melanoma-KO-120
HCC827 GR5
Hek293-EBNA1-6E ALG6/UGGT12-/-
JIMT-1
YD-10B
RPMI-8402
HSC-3
LU65
melanoma-KO-47
Hermes 3A
FULR
HAK1A
HCC-78
melanoma-KO-77
SHP-77
NCI-H1819
NCI-H1618
GRANTA-519
OC 314
MPC-11
Panc 02.13
U-138 MG
melanoma-KO-152
MV4-11
G-361
NHU12
DLD-1
KYSE-150
Q1508p1
HEK 293T
HUP-T4
K3 Induced pluripotent stem cell
OCUM-1
HL-60
NU-DUL-1
OZ
SK-MEL-1
DMS114 small cell lung cancer cell line
TO 175.T
melanoma-KO-127
NCI-H520
missing
HCCLM3
MP107R
SCC-4
BVSC R8
TC-797 (Toretsky et al. 2003)
melanoma-KO-128
CC-2550
Hs 172.T
melanoma-KO-212
Hs 616.T
FLT3-ITD+ AML cell lines (MV4-11)
PE/CA-PJ15
EB2
SH-10-TC
SHP77
melanoma-KO-38
KMS-27
SUP-HD1
melanoma-KO-100
769-P
SNU-1214
NCI-H226
SCVI-111 TBX5-Lineage Reporter Line
F9
P31/FUJ
melanoma-KO-160
melanoma-KO-220
LN229
MTB107
PTt-P2-MsNL
MDA-MB-361
CI0000034930
Hs 822.T
melanoma-KO-57
COR-L279
SNU1
Hs 343.T
Caco-2
A2780 human ovarian cancer cell line
LEC
SLR 20
Panc1-GR
hTERT-RPE1
QGP-1
YD-38
OVTOKO
TIGK
SAI5
melanoma-KO-34
NPC-L1C1
EGFP-DDX6
HSNCC
huH-1
S5
KOPN-8
1-9
PE/CA-PJ41 (clone D2)
RC1
BT-20
RL95-2
OCI-LY3
LAD2 Mast Cell
NCI-H1341
SIHA
CAL-33
melanoma-KO-276
melanoma-KO-172
AM-38
EFM-192A
MDA-MB-134-VI
NCI-H510
BM2222
GM8330
Jurkat T-lymphocytes
THP1
HUMEC
H596
Caki-1
none
melanoma-KO-28
Breast/adenocarcinoma/MDA-MB-231
L-1236
RPTEC
NCI-H1048
GI-1
LAPC9
SNU-349
LAPC4
U-118 MG
SNU-668
melanoma-KO-138
KO52
MTB64B
SK-N-AS
RERF-LC-KJ
LSPH004 iPSC
melanoma-KO-222
KE-37
melanoma-KO-240
melanoma-KO-256
THP1-derived macrophage
MiaPaCa2
KG-1
melanoma-KO-287
BC-3C
SUP-T1
IPSC-L2C1
HCC461
HRT-18
Capan-2
GP2d
3N1
melanoma-KO-145
RERF-LC-MS
--
VMRC-RCW
42-MG-BA
GM18502
TE-10
S6
NCI-H2141
BICR 31
SNB19
SGC7901
SK-GT-2
A2780cis
MONO-MAC-1
NCI-H1666
HLE cells
LP-1
T84
hTERT RPE-1
76NF2V
AGS, Hs746T, KATOIII, MKN1, MKN28, MKN45, MKN74, NCC19, NCC20, NCC24, NCC59, NCIN87, SK4, SNU1, SNU16, SNU1750, SNU1967, SNU484, NU601, SNU620, SNU638, SNU668, SNU719, YCC11, YCC16, YCC2, YCC3, YCC7
hFM-AEC
melanoma-KO-168
SNU-407
HuT 78
T1-73
breat cancer cells
HCC1500
DKO-1
Hs 695T
TGBC14TKB
PC3
DM-3
8-MG-BA
OCIMY5
melanoma-KO-121
CWR22Rv1 AR-EK
SNU-761
CCK-81
HSC-1
T-47D
MDA-MB-435S
VeroE6
107CRCR
melanoma-KO-263
COR-L51
melanoma-KO-218
GSS
UM-UC-3
melanoma-KO-193
COLO 668
HEK
melanoma-KO-68
PC3M
KMS-18
LX-2
melanoma-KO-93
CAL 27
Du145
HPV 16-immortalized gingival keratinocytes (HIGK)
BT-483
melanoma-KO-137
VMRC-RCZ
HCC-1359
Human lens epithelial cell line
LNCaP-FGC
Neuron-L2C2
UCLA1
Huh7 cells
U-937
UACC-257
22RV1
melanoma-KO-13
CMK9
RS-5
PCCB-G1
melanoma-KO-110
melanoma-KO-41
COLO-320
melanoma-KO-43
NCI-H1092
TGBC2TKB
DOHH2
BCP-1
KhES-3
PERI
hFM-AMC
HeLaXBP1s cells
HOP-62
WTC-11
SALE
KMS-20
SCC-15
HOS
HK-2
F1339
melanoma-KO-70
MR42D
VM-CUB1
UCLA6
T98G
X666
Hs 706.T
LN-443
Calu-6
BxPC-4
SAS cell
Reh
NCC20
PK-59
HPAC
RT112 urothelial carcinoma cell line
SNU-503
CD133+ D456MG
SNU-1041
melanoma-KO-183
NCI-H446
human immortalized podocyte (AB8/13)
ES2
LNCAP
melanoma-KO-190
CUTLL1
Human Umbilical Vein Endothelial Cells
Human neuroblastoma cell line SH-SY5Y
NCI-H1838
F12
SU-DHL-10
MET4
NCI-H460
Hek293
vorinostat-resistant HCT116
ESS-1
NCI-H838
NALM6
CC-2508
SW620
NC3
SZ95 sebocytes
SH-EP (Venus-overexpressing)
HeyA8 CD95 k.o. cells clone #11
RMG-I
TE-8
OAW28
NCI-H747
melanoma-KO-201
NCI-H3122
OCI-Ly7
PL-21
melanoma-KO-16
melanoma-KO-253
CRL-4003
HCjE
HBE4
ACHN
JVM-3
YCC2
HCC364
OVKATE
1-9-6
MDA-MB-231
WT hiPSC#2
H9 hESC
1-7
H9
JAR
CC-7049
melanoma-KO-271
CC-2902
NCI-H1792
NCI-H1915
JL-1
143B
melanoma-KO-203
HKC L1
HCC38
WM-115
MB468
GA-10
H3
HeLa
Hs 746T
EJM
YAPC
melanoma-KO-17
JMSU-1
HD291
KNS-81
DU4475
melanoma-KO-147
501Mel
HT-29
SW 900
SNU-81
MHH-CALL-2
OVSAHO
OCI-LY10
G-402
SF8657
KHM-1B
primary
YD-8
TUHR10TKB
LK-2
SNU-738
NCI-H2887
IMR90
HCC-1833
LUDLU-1
T24
H226
S9
HCT116
COLO 201
C42-B
NCI-H1944
melanoma-KO-107
DMS 153
Hct116
Olres-UWB1.289
JVM-2
EHEB
K562
SK-MEL-3
KATO III
Toledo
melanoma-KO-59
melanoma-KO-117
NCI-H1781
Hs 934.T
HMEC
PE/CA-PJ34 (clone C12)
Hs 606.T
ADSC
SNU-5
NCI-H2170
M23
NIH/3T3
H1
VCAP
Mino
SW 1783
melanoma-KO-10
NCI-H2126
SK-N-MC
SF268
Chap
HRMEC
NUGC-4
melanoma-KO-109
NCI-H322
SK-MEL-24
melanoma-KO-132
Caov-3
melanoma-KO-37
Hs 739.T
melanoma-KO-265
NCIN87
Hs 683
NCI-H1436
BEAS-2B
Hs 737.T
melanoma-KO-191
exosome
NCC-StC-K140
melanoma-KO-242
Hs 940.T
melanoma-KO-159
melanoma-KO-215
COV504
PCCB-G2-NC
Caov-4
NALM-1
melanoma-KO-269
HEC-108
iPSC-CM
201B6 derived ALUBUMIN reporter cell line 12C57
RC46B-R
NCI-H2023
NCI-H660
NCI-H358
SCC-9
MTB64B-R
SK-MEL-147
NCIH2882
melanoma-KO-184
CHLA-C232.3
FULVR
BFTC-909
HEPG2
COLO205
SNU-201
U937
KATOIII
BRD4 reporter KBM7 cells (REDS1 clone)
PANC-1
SNU-8
KM12
melanoma-KO-209
SLR 21
CMK
BT-474
melanoma-KO-122
WM-983B
MTB67-R
HPAFII
HEL
KMS-11
MIFF3
HCC2935
melanoma-KO-239
SK-OV-3
PA-TU-8902
Hek293-EBNA1-6E ALG6/UGGT2-/-
MB135-DUX4
H522
MM1S
NCI-H596
HuH28
HCT116oxR
OVCAR-5
NCI-H1623
MEC1
melanoma-KO-98
melanoma-KO-72
KG-1-C
TC32
MOLM14 Parental cells
HCC515
melanoma-KO-144
SK-UT-1
SNU-1
RT-112
IA-LM
LCLC-103H
HCC1395
melanoma-KO-196
H9; day 4 of differentiation
NCI-H2081
TTC1240
CC-2509
WERI-RB1
MTB15
melanoma-KO-89
NCI-H2342
TM-31
OCI-AML5
KNS-42
U87 glioma cell line
SNU-1066
melanoma-KO-161
melanoma-KO-163
melanoma-KO-7
NALM-19
COR-L24
SUP-M2
VU40T
H11
SW1463
gastric carcinoma cell line SNU-719
MDA-MB-415
MFE-296
RPMI-7951
EPC
HEC-59
melanoma-KO-202
Hep2
BxPC-6
BaF3-T315I
JHH-7
DU 145
melanoma-KO-8
T3M-4
HepG2
LS 180
IGR-1
KPMRTRY
RI-1
HEC-151
SNU-489
PC9
Hs 688(A).T
F8
Hs 274.T
A2780 cells subjected to 5 cycles of cisplatin treatment as described (PMID: 9041185).
GES-1
SCH
melanoma-KO-4
H1 hESC cell line
A375
F1
TCCSUP
Hs 751.T
melanoma-KO-113
LOU-NH91
KYSE-180
451Lu
BHY
Daoy
GM21
SNU1750
primary cells
Daudi
GL261fluc
MOLM13
OPM-2
melanoma-KO-223
OVCAR-4
NCI-H196
NCI-H2077;NCI-H1581
SNU-245
KM-H2
HCC-1438
HCC2450
melanoma-KO-84
AU565
CHLA-C229.2
NCC59
DMS 273
CGTH-W-1
U2OS pTRIPZ-YFP-ER-E2F1
Y79
Q1039
SZ-HU-MO-2
MV-4-11
501MEL
H6
ONS-76
NCI-H2196
SF-295
MET1
snu719 parental
HCC-1171
GSC267
MRC-5 (ATCC, CCL-171)
Hep 3B2.1-7
Hs746T
NOS
M-07e
SKNO-1
melanoma-KO-92
DV-90
derived from Ramos
HeLa cell line
NUGC3
KARPAS-299
SBC-3
LC-1F
melanoma-KO-82
HEK293
BT16
melanoma-KO-277
NCI-H1650 and NCI-H1975
HT1376
MEC-1
JHH-4
ST88-14
Raji
melanoma-KO-162
NCI-H1975
Hs 819.T
Hs 870.T
DB
Thp1
NCI-H1963
AML-193
HUCCT1
HEC-1-A
NCI-H226 (CRL-5826)
NCI-H2009
Primary fibroblast
SK-HEP-1
HuTu 80
MV411
NCI-H929
melanoma-KO-158
H8
UM-UC-1
M059K
melanoma-KO-251
human KMT2A rearranged MV4;11 AML cell line
H1299
melanoma-KO-232
LMSU
melanoma-KO-94
COR-L88
PC-14
melanoma-KO-14
MDA MB-231
NCI-H889
STM9101
KYSE-520
Calu-3
melanoma-KO-133
Craig Venter-B (CVB) hiPSC subline
TS543
NKYS
MOLT-3
GDM-1
CACO2
WT Hek293-EBNA1-6E
mesenchymal
EWS502
PA1
MONO-MAC-6
T265
NMC-G1
melanoma-KO-180
HEK TE
melanoma-KO-112
C4-2B prostate cancer
melanoma-KO-173
teloHAEC
CHLA-C275.2
HuG1-N
HKC L2
H6c7
HUES6
induced neurons
SHEP MYCN
TGBC11TKB
HEC-6
melanoma-KO-198
SNU-387
CCLP1
COLO-699
SW837
TYK-nu
Hs 611.T
melanoma-KO-15
melanoma-KO-286
1-7-5
HMC-1-8
SNU-119
CAL-29
MHH-CALL-4
C3651
SNU-840
melanoma-KO-29
Hs 821.T
hFM-DEC
melanoma-KO-11
SMS-KCN
NCI-H2452
SW1116
OE33
SNU1967
melanoma-KO-210
HDMYZ
Q1269p1
melanoma-KO-67
BEAS-2B cell line
C3649
SLR 23
Wtc11
Co-EVs: mEVs and sEVs were isolated from control vector (pCDNA) expressing MDA-MB231T cells.
Human astocyte cell line
HeLa S2
JHUEM-7
NCI-H1155
SW 1353
SK-MM-2
GCT
Hep3B
RH-18
melanoma-KO-166
melanoma-KO-284
MRC5
RD ERMS
HS360
NPC-L1C2
SNU-213
melanoma-KO-134
HCB1
Hek293-EBNA1-6E ALG6-/-
melanoma-KO-268
LAMA-84
melanoma-KO-254
SLR 26
SCVI-111
bronchial epithelial cell
TM87
CHLA-C275.4
HMLER
KP-3
G-401
CAS-1
MDA MB-436
MCF10A
melanoma-KO-46
NHC3
melanoma-KO-182
WA01 (H1 ES)
melanoma-KO-219
BT-549
NCH601
CAL-85-1
SU-DHL-8
melanoma-KO-155
N/TERT-2G
melanoma-KO-208
CHLA-C232.2
OCI-Ly8
H157
Kyse150
UWB1.289
K562 erythroleukemia cell line
A-673
hPSC
CL-11
U2OS cell line
UOK101
melanoma-KO-66
IGROV1
CEM.NKR.DC-SIGN
SCC-9 cells
CAL-54
MDA-MB-330
SNU216
UPN2
NCI-H2405
A101D
KYSE150
SUP-T11
ACC-MESO-1
KNS-62
VCaP
CH-157MN
SHEP parental cells
HD-MY-Z
HCT15
NCI-H526
KP-N-YN
SK-RC-20
Knee OA dervied chondrocytes
H1437
U2
WM-793
HCC1428
CT27
melanoma-KO-130
L-363
Di-DS3
KMBC-2
HGC-27
RL
MEL-HO
NALM-6
TTC642
TC7 (RRID:CVCL_S881)
FTC-238
HT-1080
GM12878
MOLT-13
KARPAS-620
NOK
melanoma-KO-114
H9 human embryonic stem cells
HeLa (sh FBL integrated)
SF767
DK-MG
LS174T
HT55
SNU-61
U87MG
LCL1
SCC12
UCLA5
CuFi-1 Cell Line
TTC709
FaDu
Loucy
NIH-3T3
KMS-34
U-2 OS
melanoma-KO-234
PSN1
Mixture of U87 and 67NR
JURL-MK1
GM12890
JHUEM-1
AN3 CA
MDA-MB-231 lung metastatic cells LM2
SW 1990
RERF-LC-Sq1
BxPC-5
HAK1B
Hs 729
NCI-H650
Kasumi1
TC-71
RERF-LC-Ad2
OE21
HMEL
MG
SNU-685
Hs 255.T
CI-1
1015 (Grayson et al. 2014)
melanoma-KO-189
SUP-B15
KP-2
ME-1
HT-144
KGN
BE2N
Hs 578T
Panc.10.05
Hs 852.T
MOLT4
MUTZ-3
melanoma-KO-177
melanoma-KO-104
PTt-P3-MsNL
SNU-410
EGI-1
CL-40
melanoma-KO-241
MTCHC01
AIRE-Tet, Tet-On Advanced HEK293 (Clontech) with inducible AIRE expression
GM12881
prostate cancer cell line C42B
PA-TU-8988S
ZR75-1
MCF-10A
MOR/CPR
NCI-H524
RCC10RGB
OCI-LY-19
MOLM-6
RC1R
H9 Embryonic stem cell
DU145 tumor cell line
PF-382
HCER
melanoma-KO-270
H460 cell line
H4
Latently infected N6 clone of Jurkat cell line
COV318
NPC-L2C2
GM12879
DU145
C70R
SKOV3
NCI-H211
HCC-2279
SKM-1
LNCaP clone FGC
melanoma-KO-278
Panc 10.05
NCI-H1581
H460
TE-5
UO-31
MKN-45
NCI-H1755
OCI-C5x
HCC-15
OPM-1
NH-6
ZR-75-30
HuCCT1
TSU-Pr1
PTt-P1-MsNL
Saos-2
PCCB-G2-3
TF1 hematopoietic cell line
YF29
H9; day 1 of differentiation
Capan-1
SKOV3(HTB77)
KPL-1
melanoma-KO-3
ABC-1
CAL-148
LNCaP95
HCC202
JHOM-2B
D10
NOMO1
SNU620
Ki-JK
HEC1A
EC-GI-10
DMS 454
HOP-92
HNES2
RS4;11
HCC-56
JHOM-1
melanoma-KO-1
S1
THP-1 cell line
TCC-PAN2
Hy1-29
Hs 944.T
KCL-22
293TB4Nf
SK4
DLBCL cell line LY1
Human hair follicle dermal papilla cell (HFDPC)
HCC-1195
HELA
melanoma-KO-235
MB135
MCF72a-LTED
TFK-1
SK-MEL-28
HepG2 hepatocellular carcinoma cell line
CHLA-C229.3
SNU-1105
Hy2-9
NCI-H841
LLC12PH
BICR 6
PTt-P4-MsNL
JHH-2
KYSE-450
TE 125.T
OCUM1
MDA-MB-231-LM2
192907
Kasumi-6
G15.AO
PK-1
Pfeiffer
NY
ECC10
NCI-H522
GOS-3
SF126
HEC-265
U87
GM12888
P3HR-1
Hep G2
melanoma-KO-79
hFOB1.19
22Rv1
KASUMI-1
HBE2
KOPTK1
PC9 U937 mix
PBMC
C49R
FU-OV-1
NCI-H2228
R225X LMNA mutant hiPSCs
BICR 18
RC46B
GM12884
HAP1
huh7.5.1
PCCB-G1-NC
melanoma-KO-148
IGR-37
iPSC
CC-2538
L1207
MON
melanoma-KO-115
SNU-886
GM12889
COLO-800
NHBE
Olres-UWB1.289+BRCA1
NCI-H2227
TUHR4TKB
SNB75
NCI-H684
NU-DHL-1
EVSA-T
melanoma-KO-124
OELE
SNU668
UCLA2
A1207
NCI-H2172
Huh7
639-V
melanoma-KO-231
melanoma-KO-230
72
SZ-HU-PROB
CMK-11-5
TMD8
COLO 741
H69
HCC-LM3
SNU-C1
ONCO-DG-1
SKPNDW
Molm-14
HSC-4
cutaneous T cell lymphoma cells
194987
HT29
PCM6
KU812
HCC2429
Hela
SK-MEL-5
Hy1-30
GM12883
SAS
LN-428
mESC
EA.hy926
melanoma-KO-156
Hy1-25
F6
MDA-PCA-2B
melanoma-KO-25
JHOC5
SW48
human iPSC-derived neurons
THP-1
RERF-LC-AI
melanoma-KO-226
MFE-280
A-253
melanoma-KO-60
Hs 618.T
MCF7-derived LY2
BICR 16
HEK 293
SNU-1197
melanoma-KO-169
SW579
NCI-H1703
SK-N-SH
HCC1954
UT-7
HEC-1-B
Huh7.5
5637
A375 melanoma cell line
HT-1197
melanoma-KO-85
TMZ-resistant U87MG
Panc1
HCCLM3 cells
MKN1
NOMO-1
HEK293E
NCI-H1435
SMS-KCNR
H1 hESC
KMRC-2
Lis46
MEL-JUSO
WM1799
C32
NCI-H2087
UCLA3
BT-12
U-BLC1
DKs-8
OA-MSC2
Kupffer cells (Primary culture (Life technologies))
Hs 839.T
SNU484
HEC-50B
HA1ER
melanoma-KO-61
HSC-2
SNU-475
BJAB
MCF7-DoxoR
NCI-H2347
melanoma-KO-78
MeWo
COR-L47
IOMM-Lee
MG-63
melanoma-KO-280
periodontal ligament cells
Hs 840.T
NCI-H1184
PGP1 cell line, Coriell Institute, male
L-428
C42B
melanoma-KO-21
melanoma-KO-19
LC-1/sq-SF
NCH644
CL-14
Hek293-EBNA1-6E ALG6/UGGT1-/-
BT12
S8
SLR 25
SK-LU-1
MCF-7
SCaBER
ECC12
MP107
DOV13
LN-340
OV7
MDA-MB-231 cells
LS123
melanoma-KO-175
107CRC
NCI-H1876
melanoma-KO-260-262
CHLA-ONH348.3
NCI-H209
LS1034
NCI-H716
SNU-C4
HCC70
HDQ-P1
RD-ES
NHP cells
NCI-H2085
GSU
HuNS1
TE-14
KP-1N
NCI-H2110
MDA-MB231 cells
B-CPAP
TF-1
SBC-5
PANC-1-GR
CC-2565
PEER
melanoma-KO-123
GB-1
COLO-704
Hy2-16
PE/CA-PJ49
NKX2.5eGFP/+-COUP-TFIImCherry/+
melanoma-KO-64
EM-2
S4
MTB67
ChaGo-K-1
melanoma-KO-32
NIH3T3
melanoma-KO-213
CHLA-C232.1
OVMANA
MiaPaCa
SW480
H1 hESCs
BLaER1
NuLi-1 Cell Line
OCI-M1
NCC24
HCC-1588
NCI-H2444
AALE
RERF-GC-1B
Ovcar8
MKN7
SUIT-2
585A1
Vero E6 African Green Monkey kidney cell line
SEM
melanoma-KO-244
A427
NCI-H2286
J82
L0615
Hey-A8
REC-1
IMR-32
CC-2587
LN-464
SCC-25
Lis39
HFF-1 (ATCC SCRC-1041)
UO9
huh7
RPMI 8226
SF539
BOFS hiPSC cl3
HEMn-LP
T47
T47D
MOLP-8
HUES9 subline
AMO-1
CASKI
KMRC-20
647-V
Kg1a
LNCaP-abl (abl)
WM-88
P493
LCLC-97TM1
melanoma-KO-250
OS-RC-2
COR-L23
SW-1710
OV-90
CACO2;CACO2;CaCo-2
HCC-366
BL-70
RPMI 6666
Embryonic kidney cell line HEK293T
melanoma-KO-125
SNU-C2A
C3647
C42-B-Abi
EFO-27
LN382
JHH-6
Tri-DS3
ALL-SIL
melanoma-KO-181
Human HDMB03 group 3 medulloblastoma cell line
RVH-421
SU.86.86
SCC13
TOV-21G
HCT116 cells
OVCAR-8
VMRC-LCD
KYSE-510
stem cell
D149 iPSC
SNU-308
AMC-HN-8
HCC1806
SNU-1196
NSB3188 (iPSC)
KMS-26
SU-DHL-1
SKMES1
Panc-1
EBC-1
melanoma-KO-108
Kyse30
KE-97
OUMS-23
SNU-182
Ishikawa
SW948
HCT 116
MOLT-4
JK-1
SW1417
melanoma-KO-142
microvascular
Panc 04.03
C8166
MKN45
WM-266-4
melanoma-KO-146
melanoma-KO-188
SW 1088
NCI-H1385
CT1258 (TihoDProAdcarc1258)
SU-DHL-4
BxPC-8
BT474
HUVEC
BV-173
SKMEL-2
DMS 79
JEG-3
BJ
BOFS hiPSC cl1
SMS-CTR
Panc 08.13
BRD4 reporter KBM7 cells (REDS15 clone)
LNCaP
ZR75
Malme-3M
NCO2
GR-M
NCI-H1299
SNU-423
Panc 05.04
SNU-216
melanoma-KO-53
CAL-51
UMUC3
KP4
NCI-H661
MHH-CALL-3
SIMA
#9
192627
NCH421k
PTt-P8-MsNL
melanoma-KO-90
UMUC9
NCI-H1105
MV4;11
MDA-MB-453
HK2
DND-41
PrEC
MDA-MB-231(HTB-161)
Panc8
EN
SK-MEL-31
SNU-1033
NKX2.5:GFP hESCs
COR-L95
melanoma-KO-216
SNU-620
VMRC-LCP
TE-11
NCI-H441
NCI-H1437
CHLA-ONH232.3
melanoma-KO-2
SH-EP (MYCN overexpressing)
U-87 MG
Hs 742.T
KYM-1
ADR
HCC-44
SNU-478
BDCM
RCC4
Craig Venter-B (CVB) hiPSC line
HuT 102
DEL
SRSF6-GFP
253J
GOT1
EFE-184
Hs 863.T
G402
SK-ES-1
H12
JJN-3
naive induced pluripotent stem cells
Sezary Sydrome
MTB80
RH-30
SNU-398
NPC-L2C1
DMS 114
MDA-MB-436
SLK
HCC1599
S11
HT-1080 fibrosarcoma
H5
melanoma-KO-187
melanoma-KO-275
COLO-818
MDCK
Ishikawa (Heraklio) 02 ER-
MEG-01
NCI-H2052
melanoma-KO-91
Hs 698.T
Li-7
HEK293T and 3T3
HCET
melanoma-KO-102
K562 RNASE1-WT
MOLP-2
iSLK.219
TOV21G
Lis45
MOTN-1
Panc 03.27
786-O cells
KYSE-410
CC-2556
KP-N-SI9s
melanoma-KO-205
NUGC-3
ES03
PA-TU-8988T
SNU-520
CHL-1
NCI-H1930
N/A
RPMI-8226
melanoma-KO-27
EW8
BT67
HeyA8
melanoma-KO-186
TC28a2
NCI-H647
C2517A
S2
COLO 792
HL60/S4
MTB80R
not applicable
SW 780
MGH26
KYSE-30
MHH-NB-11
DND41
Human Embryonic Kidney (HEK) 293T-Rex
HepaRGTM cells (HPR 116)
STK32B
GM12882
CI0000035099
melanoma-KO-170
LOX IMVI
HT
melanoma-KO-101
HuH7
HARA
GM12892
OUMS-27
melanoma-KO-111
TKKK
RUES-2
KALS-1
TPC-1
melanoma-KO-154
YKG1
CCF-STTG1
HeLa-229 (ATCC CCL-2.1)
CHLA-ONH229.3
SZ-HU-MO
alveolar epithelial cell
Human umbilical vein endothelial cells
RERF-LC-Ad1
FTC-133
Hs 834.T
BjhTERT
HTK-
melanoma-KO-95
control1
Molm13
MMC70
JHUEM-3
melanoma-KO-192
S7
SU-DHL-6
KYSE-140
KELLY
SK-N-BE(2)
HMEC-1
IPSC-L1C2
L3.3
SNU-719
NCI-H810
melanoma-KO-87
melanoma-KO-228
LASCPC01
UACC812
MSTO-211H
K029AX
N87
COLO 829
MDA-MB-175-VII
HeLa CRISPR/Cas9 clone E7
H929
EFO-21
BT89
G9_pCDH
SU-DHL-5
melanoma-KO-247
MM1-S
CC-2527
8305C
OE19
KE-39
NA
585B1-868
SH-SY5Y
FU97
melanoma-KO-35
HBE3
SZ-HU-FA
TAMR
KLE
U343
melanoma-KO-63
FGF2 Early Gilteritinib Resistant MOLM14 cells after 48hr Gilteritinib Treatment
Detroit 562
LoVo
A2058
SCC23
AALE cells
CC-2553
n/a
Hs 604.T
HuH-7
NUGC-2
HNT-34
SNU-1077
C4-2
LS513
HT22
CC-2931
SUDHL4
iCell Glutaneurons
786-O
Caki-2
SUM1315
SNG-M
L02 cells
D149 NSC
NCI-H1563
A431
LU99
NCI-H2004 RT
CFPAC-1
KG-1a
NOZ
CTR M3 36S
CC-2559
melanoma-KO-227
F2
U266B1
CC-2511
78
LN-235
NCI-H28
melanoma-KO-22
HT115
BL-41
NCI-H2122
Hs 229.T
Neuron-L1C2
HeLa CRISPR/Cas9 clone B13
NCI-H1651
Calu-1
HCC-95
MonoMac6
BE-(2)-C
RKO
59M
Q1007
COLO-783
SNU-1272
SR-786
melanoma-KO-42
DIPG-IV
JHOC-5
OVCA433 cells
OC 316
TTC549
NCI-H2029
Hs 600.T
ST486
SNU638
HCT-15
SNU16
UACC-812
OCI-AML3
697
KMS-28BM
Monomac
SJSA-1
SNU-C5
H9; day 2 of differentiation
IMR90 human primary lung fetal fibroblasts
H2
SNU-175
NCI-H2030
HAP1 cells
RH-41
KARPAS-422
BJ Fibroblast
CW-2
human foreskin fibroblast cell line HCA2
snu-4th highly malignant
ZR751
Oral squamous carcinoma
HEK-293T
COLO 775
RD
melanoma-KO-214
NCI-H2106
KMS-21BM
NCI-H1650
Moml13
COLO-679
nCSC
SiHa
MRC-5 cells
H10
LN-229
NCI-H1793
NCI-H1355
melanoma-KO-76
Neuron-L2C1
HCC1143
CC-2904
HCC1569
hematopoietic cells
Lis38
MHCC-97H
GM12880
HMCB
COR-L311
EaHy
melanoma-KO-65
SNU-283
melanoma-KO-56
melanoma-KO-81
G2
SiHa cell
C3A
Hs 281.T
F10
THLE-2
TT
hFM-CTC
melanoma-KO-282
TE-9
TE 617.T
melanoma-KO-236
A-498
MB135 iDUX4
SG231
#8
KMRC-1
SK-N-DZ
MPP 89
RT4
NCI-H1869
L0125
H9; day 3 of differentiation
TOV-112D
MOG-G-CCM
melanoma-KO-204
HCC-33
HaCaT
melanoma-KO-45
NCI-H1373
GM12887
SNU-449
HDLM-2
ES-2
BE(2)-m17 (ATCC CRL-2267)
HEL 92.1.7
MONO-ALLELIC mEGFP-TAGGED TTN WTC iPSC LINE (TAG AT C-TERM)
PC10
YCC11
MDA PCa 2b
NHU11
MOLM-13
SW13
HPCOA07/03
melanoma-KO-151
SNU-324
S-117
melanoma-KO-141
AsPC-1
AB9
H295R
NCI-H2291
Hek 293
MDST8
